Navigation Links
MiddleBrook Pharmaceuticals Reports Third Quarter 2007 Results
Date:11/14/2007

to common stockholders during the first nine months of 2007 was ($0.78), down from a net loss per share of ($0.93) in the first nine months of 2006.

"We believe the Amoxicillin PULSYS NDA review process has progressed very well thus far and we look forward to continuing to work with the FDA throughout the remainder of their review," stated Edward M. Rudnic, Ph.D., president and CEO of MiddleBrook.

OPERATIONAL HIGHLIGHTS

Amoxicillin PULSYS NDA Review -- PDUFA Date January 23, 2008

On May 22, 2007, MiddleBrook's New Drug Application (NDA) for its once- daily Amoxicillin PULSYS product was accepted for filing by the U.S. Food and Drug Administration (FDA). MiddleBrook has worked closely with the FDA throughout the subsequent review process and anticipates a decision on the application on its Prescription Drug User Fee Act (PDUFA) target action date of January 23, 2008.

Amoxicillin is currently not approved for once-daily dosing to treat pharyngitis. If approved for marketing, physicians prescribing Amoxicillin PULSYS would have available the first once-daily product in the aminopenicillin class for the treatment of pharyngitis while utilizing approximately one-half the amount of amoxicillin currently used. About 15 million patients annually seek relief of sore throat symptoms in the United States.

Keflex(R) Capsules (Cephalexin, USP) -- Commercialization Update

During the third quarter, MiddleBrook continued the commercialization of its 750 mg strength Keflex capsules through a targeted and dedicated national contract sales force and MiddleBrook district sales managers. Based on prescription data from IMS Health, total prescriptions filled for Keflex 750 mg capsules in the third quarter of 2007 were 83,767 prescriptions, up from second quarter 2007 total prescriptions of 82,621.

MiddleBrook recently conducted a review of its Keflex sales initiatives and as a result reduced the size of its sales force to approximately 30 c
'/>"/>

SOURCE MiddleBrook Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related medicine news :

1. MiddleBrook Pharmaceuticals Raises Up to $10 Million from Deerfield Management
2. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
3. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
4. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
5. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
6. Vista Partners Updates Coverage on Tapestry Pharmaceuticals
7. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
8. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc.
9. Amylin Pharmaceuticals to Webcast Corporate Overview During 43rd Annual Meeting of the European Association for the Study of Diabetes
10. Major Pharma Clinical Case Studies From Amgen, AstraZeneca, GSK, Intermune, Cephalon Inc, Sunesis Pharmaceuticals and Dartmouth Medical School During Fall Clinical Focused Programs
11. Provectus Pharmaceuticals, Inc. releases summary results of phase 1 metastatic melanoma study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... ... ... sweetFrog Enterprises, LLC. is pleased to announce the opening of its newest ... the Lone Star State. The premium frozen yogurt chain was listed as #22 on ... opened July 1 at Duke’s Travel Plaza, is located at:, 30176 Hwy 64, Suite ...
(Date:7/2/2015)... ... July 02, 2015 , ... When Walker Parking Consultants specified ... of Minnesota, they knew it would save the university energy and maintenance costs. ... the total energy savings after installation was an impressive 89 percent, which resulted ...
(Date:7/2/2015)... Bolingbrook, IL (PRWEB) , ... July 02, 2015 , ... In 2012, Patrick Achebe realized ... when he was alone. He sat down to write his first poem, and three years ... of him that was special and worth sharing with the world. "I have always believed ...
(Date:7/2/2015)... , ... July 02, 2015 , ... ... newest shades of the SIGVARIS PERFORMANCE SOCKS. Since the socks were first introduced, ... athletic trainers. Their significant popularity has inspired four new, fun shades including: blue, ...
(Date:7/2/2015)... ... July 02, 2015 , ... The ZAC Foundation, a national leader in ... important lessons on how to stay water safe with the help of a young ... by The ZAC Foundation co-founders, follows Zeke’s water safety journey. Zeke, who is ...
Breaking Medicine News(10 mins):Health News:sweetFrog Expands Texas Footprint with Location in Canton 2Health News:Kenall’s TekDek™ Helps University Achieve Award-Winning Energy Savings in Parking Structure Lighting Retrofit 2Health News:Patrick Achebe Releases Debut Book, Whispering Waves: Poems for Everyday Grace 2Health News:SIGVARIS is Sporting Four Brand New Colors in the Popular PERFORMANCE SOCK Product Line 2Health News:The ZAC Foundation Kicks Off Summer and July 4th Weekend with Complimentary Children’s E-Book on Water Safety 2Health News:The ZAC Foundation Kicks Off Summer and July 4th Weekend with Complimentary Children’s E-Book on Water Safety 3
... 17-year-old boy needs cancer treatment, PacifiCare denies, ... concerned community members will join the family of ... insurance giant PacifiCare in,Orange County this Tuesday to ... the 17-year-old, the California Nurses Association/National,Nurses Organizing Committee ...
... &,Anaphylaxis Network (FAAN) will hold its 15th annual Food ... families struggle,with how best to manage food allergies in ... for years or are dealing with a new,diagnosis, this ... and strategies for living better,while managing food allergies. Topics ...
... Research Hospital have demonstrated that children with bilateral ... retain normal function in both kidneys by undergoing ... preoperative scans suggest that the tumors are inoperable. ... Jude patients with bilateral Wilms tumor exhibiting favorable ...
... risk factors with their doctors, SCHAUMBURG, Ill., ... that,psoriasis, a chronic skin condition characterized by thick, ... a significant negative impact on a,patient,s overall quality ... severe psoriasis, is linked with a number of ...
... WASHINGTON, March 24 , WHO: STELLA MORA HENRY, AUTHOR OF THE ELDERCARE HANDBOOK, ... to answer any questions or concerns about eldercare and ... WHEN: March 27, 2008 2:00 PM - 4:30 PM ... 1:00 PM & 4:00 PM - 6:00 PM ...
... improved symptoms, avoided rejection , , MONDAY, March 24 ... disease in mice, researchers report. , Using the ... genetic profile to each mouse being treated allowed ... the diseased animals, without provoking any evidence of ...
Cached Medicine News:Health News:Life Denied: Nurses, Family of Sick Teen March on Health Insurance Company Tuesday 2Health News:FAAN Brings 'Food Allergies: Living and Learning' to Annual Food Allergy Conference in Baltimore 2Health News:FAAN Brings 'Food Allergies: Living and Learning' to Annual Food Allergy Conference in Baltimore 3Health News:St. Jude study offers new hope for children with kidney tumors deemed inoperable 2Health News:Research Shows Patients With Psoriasis at Increased Risk for Developing Other Serious Medical Conditions 2Health News:Research Shows Patients With Psoriasis at Increased Risk for Developing Other Serious Medical Conditions 3Health News:Research Shows Patients With Psoriasis at Increased Risk for Developing Other Serious Medical Conditions 4Health News:Stella Mora Henry to Present The Eldercare Handbook at 'Aging in America' Joint Conference of National Council on Aging & The American Society on Aging March 27-29 2Health News:Therapeutic Cloning Works in Mice With Parkinson's 2Health News:Therapeutic Cloning Works in Mice With Parkinson's 3
(Date:7/2/2015)... , July 3, 2015 ... adquisición del 100% de participación en ZAO "Biocom" ... adquisición marca la incursión de Lupin en el ... de RUB en ventas, colocándolo como uno de ... 2014 (IMS Health). Durante más de una década, ...
(Date:7/2/2015)... DIEGO , July 2, 2015 ResMed Inc. ... its fourth quarter and fiscal year ended June 30, 2015 ... Stock Exchange market close. A press release with ResMed,s results ... the company will host a webcast to discuss operating results ... to begin at 1:30 p.m. US Pacific Time and the ...
(Date:7/2/2015)... -- Releases of the genetically engineered Oxitec ... , , reduced the dengue mosquito population in an ... 95%, well below the modelled threshold for epidemic disease ... The journal PLOS Neglected Tropical Diseases published today the ... The results showed that in Juazeiro city, northeast ...
Breaking Medicine Technology:Lupin adquiere Biocom en Rusia 2Lupin adquiere Biocom en Rusia 3ResMed to Announce Fourth Quarter and Fiscal Year-End 2015 Results 2Oxitec Mosquito Works to Control Aedes aegypti in Dengue Hotspot 2Oxitec Mosquito Works to Control Aedes aegypti in Dengue Hotspot 3
... 3, 2011 Coast Dental Services, Inc., announced today ... the assets of Dental Technology, Inc. (DTI), doing business ... licensed  health care service plan. DTI and its subsidiaries ... Texas, employing 1,200 staff members, including 130 dentists.  The ...
... Mass., May 3, 2011 Alere Inc. (NYSE: ... charge of their health at home through the merger of ... attend the Deutsche Bank 36th Annual Health Care Conference being ... Russell, Vice President, Finance, will attend.  Mr. Russell,s presentation is ...
Cached Medicine Technology:Coast Dental to Acquire the Assets of SmileCare 2
Intermittent catheter...
Intermittent catheter...
Enhanced drug and formulary reference with integrated ID treatment guide and tools. Increase patient safety and satisfaction with our premium drug reference....
... Tailor Flexible Band is a flexible ... time-saving alternative for surgeons who desire ... SJM Tailor® Annuloplasty Ring, which is ... full rings, but like the option ...
Medicine Products: